PetMed Express appoints Jeff Willard as CEO, effective Sept. 28; Leslie Campbell retires as Chair

PETMED EXPRESS INC

Jeff Willard named CEO & President effective Sept. 28, 2026; succeeds Leslie Campbell, who retires as Chair & interim CEO; Justin Mennen becomes Board Chair.
Willard gets $550k base salary, $120k signing bonus, $50k relocation, target bonus 75% of salary, plus 250k RSAs and up to 250k PSUs.
Future annual LTI target $750k; initial PSUs vest on 3-yr TSR vs S&P 600 Specialty Retail Index.
Campbell to remain Strategic Advisor for 60 days; Mennen becomes Chair, Batushansky takes over governance committee chair.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey Allen Willard

Chief Executive Officer and President

PETS · PETMED EXPRESS INC

Effective: 2026-09-28
Filed: September 17, 2026, 9:08 AM ET

On September 17, 2026, PetMed Express, Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company has appointed Jeffrey Allen Willard as the Company’s new Chief Executive Officer and President.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Allen Willard was appointed as Chief Executive Officer and President at PETMED EXPRESS INC.

Action: appointed
Role: Chief Executive Officer and President

Exact text from the filing

On September 17, 2026, PetMed Express, Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company has appointed Jeffrey Allen Willard as the Company’s new Chief Executive Officer and President.

View on SEC.gov

PETMED EXPRESS INC filing history →

Source: SEC EDGAR

accession 0001040130-26-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.